Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Heparin-binding domain of IGFBP-2 in the treatment of metabolic disorders

Heparin-binding domain of IGFBP-2 in the treatment of metabolic disorders

US Patent 11192932 · Granted Dec 7, 2021

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Method of treating AML with PEGylated l-asparaginase2025
Pegylated L-asparaginase2023
PEGylated L-asparaginase2021
Compounds, compositions and uses thereof for improvement of bone disorders2021
Compounds, compositions and uses thereof for improvement of bone disorders2021
Compounds, compositions and uses thereof for improvement of bone disorders2021
PEGylated L-asparaginase2018
Monoclonal antibodies for enhancing or inhibiting insulin-like growth factor-I2018
Monoclonal antibodies for enhancing or inhibiting insulin-like growth factor 1 (2017
Modulation of ghrelin levels and ghrelin/unacylated ghrelin ratio using unacylat2017
Antagonists of IAP-SHPS1 interaction2016
Compounds and methods for treating bone disorders and controlling weight2015